Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew Winkler currently holds 50,000 shares of Akoya Biosciences, Inc. (AKYA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Winkler has been a net buyer of AKYA stock. They have purchased $1.0M and sold $0 worth of shares.
Matthew Winkler's most recent insider trade was on Jul 8, 2025, when they sold 984,513 shares at $0.00 per share.
Matthew Winkler serves as Executive at Akoya Biosciences, Inc. (AKYA). They have executed 17 insider transactions totaling $1.0M over their tenure at the company.
Matthew Winkler holds the position of Executive at Akoya Biosciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Matthew Winkler has shown a buying trading pattern, with $1.0M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Matthew Winkler was on Jun 12, 2023, when they purchased $1.0M worth of AKYA shares. This transaction involved 203,388 shares at $5.00 per share.
Matthew Winkler currently owns 50,000 shares of Akoya Biosciences, Inc. (AKYA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew Winkler's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew Winkler has 17 Form 4 filings on record as an insider at Akoya Biosciences, Inc..
Set alerts for Matthew Winkler and 40,000+ other insiders.